Dr. Lisa Rabinowitz said there were no cases of myocarditis, no allergic reactions and no deaths during trials for the vaccines. Plus, she said, the doses given to older groups have provided scientists with additional data.
“The pediatric population is a protected population, so if you’re wondering why this is coming so late in the game, we really take this population so seriously,” she said. “All the adults, all the older children, those trials happened first. We have the benefit of millions of doses to look at, in terms of safety and efficacy, before they started trials in this younger age group.”
Pfizer has a two-dose pediatric vaccine, and Moderna has a three-dose vaccine. Spacing between the doses varies depending on the brand. Rabinowitz said not all pediatricians and clinics will have both brands in stock, so parents should opt for whichever one is available from their provider. She said parents should talk to their pediatricians about any questions or concerns.are fully vaccinated against COVID-19. The state has yet to publish data on vaccine rates for the youngest group.
AnchorageAction Very exciting progress. Thank goodness for our medical community. 💙
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: AKpublicnews - 🏆 387. / 55 Read more »